Latest Breaking News On - Assess safety - Page 1 : comparemela.com

FDA Grants Orphan Drug Designation to AGMB-447 for Idiopathic Pulmonary Fibrosis

Currently, the drug is being evaluated in a phase 1 clinical trial to determine the safety and efficacy in patients.

Philippe wieselPhasei studyAssess safetyHealthy participantsParticipants withAgomab therapeuticsAgomab receivesDrug designationIdiopathic pulmonaryAccessed june

PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomJames mcarthurSarah suttonNoel donnellyPepgen incDrug administrationRegulatory agencyInternational myotonic dystrophy consortiumMuscular dystrophy associationDuchenne muscular dystrophyEnhanced delivery oligonucleotideRare pediatric disease designationsOrphan drugDystrophy associationRepeat dose nonclinical data

Inside information: Faron Presents Phase 1 Data from BEXMAB in Myeloid Malignancies Trial at the 65th American Society of Hematology (ASH) Annual Meeting

Inside information: Faron Presents Phase 1 Data from BEXMAB in Myeloid Malignancies Trial at the 65th American Society of Hematology (ASH) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesEteläuomen läiSan diego convention centerSan diegoLindsey nevilleSandy jamiesonMika kontroMary jane elliottJo turnerMarkku jalkanenChristopher goldenJuha karttunenDavid daleyAmerican society of hematologyFaron pharmaceuticals ltdHelsinki university hospital

Nanotechnology Now - EC Asks SCCS to Assess Safety of Hydroxyapatite (Nano) in View of New Information

Nanotechnology Now - EC Asks SCCS to Assess Safety of Hydroxyapatite (Nano) in View of New Information
nanotech-now.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nanotech-now.com Daily Mail and Mail on Sunday newspapers.

Bergeson campbellLynnl bergesonHydroxyapatite nanoNanotechnology columnsAssess safetyEuropean commissionScientific committeeConsumer safety

Faron to Present Phase 1/2 Data From BEXMAB Study of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies at the 65th American Society of Hematology Annual Meeting

Faron to Present Phase 1/2 Data From BEXMAB Study of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies at the 65th American Society of Hematology Annual Meeting
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diego convention centerSan diegoEteläuomen läiJo turnerMary jane elliottSandy jamiesonLindsey nevilleMika kontroJuha karttunenChristopher goldenDavid daleyPeel huntCairn financial advisersAmerican society of hematologyUniversity of texas md anderson cancer center